Targeting T cells for asthma

被引:21
作者
Heijink, IH
Van Oosterhout, AJM
机构
[1] Univ Groningen, Med Ctr, Lab Allergol & Pulm Dis, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1016/j.coph.2005.04.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The type 2 T-helper (Th2) lymphocyte can be regarded as an important target cell for the treatment of allergic asthma as it plays a crucial role in the initiation, progression and persistence of disease. Several strategies to target Th2 cells can be envisioned. Drugs that prevent Th2-cells from migrating into the lung tissue, such as antibodies to the chemokine receptor CCR4 and inhibitors of the adhesion molecule VLA-4, are promising for the treatment of asthma. To inhibit Th2-cell activation, novel asthma drugs that act on Th2-selective transciption factors such as GATA3 are being developed. Although initial strategies aimed to block the action of Th2-derived cytokines, the generation of counter-regulatory Th1 lymphocytes and regulatory T cells is currently being explored.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 38 条
[1]   New drugs for asthma [J].
Barnes, PJ .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (10) :831-844
[2]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[3]   Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions [J].
Bochner, BS ;
Hudson, SA ;
Xiao, HQ ;
Liu, MC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (05) :930-934
[4]   Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: Phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression [J].
Chen, CH ;
Zhang, DH ;
LaPorte, JM ;
Ray, A .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5597-5605
[5]   CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease [J].
Chung, CD ;
Kuo, F ;
Kumer, J ;
Motani, AS ;
Lawrence, CE ;
Henderson, WR ;
Venkataraman, C .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :581-587
[6]   CCR4 blockade does not inhibit allergic airways inflammation [J].
Conroy, DM ;
Jopling, LA ;
Lloyd, CM ;
Hodge, MR ;
Andrew, DP ;
Williams, TJ ;
Pease, JE ;
Sabroe, I .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (04) :558-563
[7]   The role of ICOS and other costimulatory molecules in allergy and asthma [J].
Coyle, AJ ;
Gutierrez-Ramos, JC .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 25 (3-4) :349-359
[8]   Dendritic cell-mediated T cell polarization [J].
de Jong, EC ;
Smits, HH ;
Kapsenberg, ML .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 26 (03) :289-307
[9]   Role of T cell co-stimulation in murine models of allergic asthma [J].
Deurloo, DT ;
van Oosterhout, AJM .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (01) :17-25
[10]  
Erpenbeck VJ, 2003, CHEST, V123, p370S